Subcutaneous Emphysema: Clinical Trials

1 trial for Subcutaneous Emphysema, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Terminated 1

Follow Subcutaneous Emphysema: new trials by email Literature Review of Subcutaneous Emphysema trials Research Report on Subcutaneous Emphysema

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Aralast alpha1-proteinase Inhibitor Surveillance Study
ARALAST Alpha1-Proteinase Inhibitor - Alpha1-antitrypsin Deficiency
Phase 4TerminatedBaxalta now part of Shire1272006-06-092021-05-26

Narrower conditions

alpha 1-Antitrypsin Deficiency (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Digestive System Diseases (1)  ·  Emphysema (1)  ·  Genetic Diseases, Inborn (1)  ·  Liver Diseases (1)  ·  Lung Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Respiratory Tract Diseases (1)

Sponsors

Baxalta now part of Shire (1)

Countries

United States (1)